Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein 1

Journal of Immunology

Volumn 174, Issue 1, 2005, Pages 395-403

  Lin, Chiou Feng ^a   Chiu, Shu Chen ^a   Hsiao, Yu Ling ^a   Wan, Shu Wen ^a   Lei, Huan Yao ^a   Shiau, Ai Li ^a   Liu, Hsiao Sheng ^a   Yeh, Trai Ming ^a   Chen, Shun Hua ^a   Liu, Ching Chuan ^a   Lin, Yee Shin ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN DV NS1; PROTEIN DV NS1 ANTIBODY; RANTES; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL DEATH; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; MOLECULAR MIMICRY; MOUSE; NONHUMAN; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR DISEASE; VIRUS INFECTION;

EID: 19944393873     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.1.395     Document Type: Article

References (70)

1. Henchal, E. A., and J. R. Putnak. 1990. The dengue viruses. Clin. Microbiol. Rev. 3:376.
2. Gubler, D. J. 1998. Dengue and dengue hemorrhagic fever. Clin. Microbiol. Rev. 11:480.
3. Bhakdi, S., and M. D. Kazatchkine. 1990. Pathogenesis of dengue: an alternative hypothesis. Southeast Asian J. Trop. Med. Pub. Hlth. 21:652.
4. Bielefeldt-Ohmann, H. 1997. Pathogenesis of dengue virus diseases: missing pieces in the jigsaw. Trends Microbiol. 5:409.
5. Pancharoen, C., U. Thisyakorn, and C. Thisyakorn. 2001. Dengue infection. J. Infect. Dis. Antimicrob. Agents 18:115.
6. Halstead, S. B. 2002. Dengue. Curr. Opin. Infect. Dis. 15:471.
7. Rothman, A. L., and F. A. Ennis. 1999. Immunopathogenesis of dengue hemorrhagic fever. Virology 257:1.
8. Green, S., D. W. Vaughn, S. Kalayanarooj, S. Nimmannitya, S. Suntayakorn, A. Nisalak, R. Lew, B. L. Innis, I. Kurane, A. L. Rothman, and F. A. Ennis. 1999. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J. Infect. Dis. 179:755.
9. Lei, H. Y., T. M. Yeh, H. S. Liu, Y. S. Lin, S. H. Chen, and C. C. Liu. 2001. Immunopathogenesis of dengue virus infection. J. Biomed. Sci. 8:377.
10. Halstead, S. B., C. N. Venkateshan, M. K. Gentry, and L. K. Larsen. 1984. Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies. J. Immunol. 132:1529.
11. Littaua, R., I. Kurane, and F. A. Ennis. 1990. Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J. Immunol. 144:3183.
12. Mady, B. J., D. V. Erbe, I. Kurane, M. W. Fanger, and F. A. Ennis. 1991. Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fcγ receptors. J. Immunol. 147:3139.
13. Morens, D. M. 1994. Antibody-dependent enhancement of infection and the pathogenesis of viral disease. Clin. Infect. Dis. 19:500.
14. Rico-Hesse, R., L. M. Harrison, R. A. Salas, D. Tovar, A. Nisalak, C. Ramos, J. Boshell, M. T. R. de Mesa, R. M. R. Nogueira, and A. Travassos da Rosa. 1997. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 230:244.
15. Leitmeyer, K. C., D. W. Vaughn, D. M. Watts, R. Salas, I. Villalobos de Chacon, C. Ramos, and R. Rico-Hesse. 1999. Dengue virus structural differences that correlate with pathogenesis. J. Virol. 73:4738.
16. Diamond, M. S., D. Edgil, T. G. Roberts, B. Lu, and E. Harris. 2000. Infection of human cells by dengue virus is modulated by different cell types and viral strains. J. Virol. 74:7814.
17. Vaughn, D. W., S. Green, S. Kalayanarooj, B. L. Innis, S. Nimmannitya, S. Suntayakorn, T. P. Endy, B. Raengsakulrach, A. L. Rothman, F. A. Ennis, and A. Nisalak. 2000. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 181:2.
18. Kurane, I., B. L. Innis, A. Nisalak, C. Hoke, S. Nimmannitya, A. Meager, and F. A. Ennis. 1989. Human T cell responses to dengue virus antigens: proliferative responses and interferon γ production. J. Clin. Invest. 83:506.
19. Mathew, A., I. Kurane, S. Green, D. W. Vaughn, S. Kalayanarooj, S. Suntayakorn, F. A. Ennis, and A. L. Rothman. 1999. Impaired T cell proliferation in acute dengue infection. J. Immunol. 162:5609.
20. Lin, Y. W., K. J. Wang, H. Y. Lei, Y. S. Lin, T. M. Yeh, H. S. Liu, C. C. Liu, and S. H. Chen. 2002. Virus replication and cytokine production in dengue virus-infected human B lymphocytes. J. Virol. 76:12242.
21. King, C. A., J. S. Marshall, H. Alshurafa, and R. Anderson. 2000. Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line. J. Virol. 74:7146.
22. Marianneau, P., A. M. Steffan, C. Royer, M. T. Drouet, D. Jaeck, A. Kirn, and V. Deubel. 1999. Infection of primary cultures of human Kupffer cells by Dengue virus: no viral progeny synthesis, but cytokine production is evident. J. Virol. 73:5201.
23. Wu, S. J., G. Grouard-Vogel, W. Sun, J. R. Mascola, E. Brachtel, R. Putvatana, M. K. Louder, L. Filgueira, M. A. Marovich, H. K. Wong, et al. 2000. Human skin Langerhans cells are targets of dengue virus infection. Nat. Med. 6:816.
24. Ho, L. J., J. J. Wang, M. F. Shaio, C. L. Kao, D. M. Chang, S. W. Han, and J. H. Lai. 2001. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J. Immunol. 166:1499.
25. Libraty, D. H., S. Pichyangkul, C. Ajariyakhajorn, T. P. Endy, and F. A. Ennis. 2001. Human dendritic cells are activated by dengue virus infection: enhancement by γ interferon and implications for disease pathogenesis. J. Virol. 75:3501.
26. Huang, Y. H., H. Y. Lei, H. S. Liu, Y. S. Lin, C. C. Liu, and T. M. Yeh. 2000. Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am. J. Trop. Med. Hyg. 63:71.
27. Avirutnan, P., P. Malasit, B. Seliger, S. Bhakdi, and M. Husmann. 1998. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J. Immunol. 161:6338.
28. Despres, P., M. Flamand, P.-E. Ceccaldi, and V. Deubel. 1996. Human isolates of dengue type 1 virus induce apoptosis in mouse neuroblastoma cells. J. Virol. 70:4090.
29. Marianneau, P., A. Cardona, L. Edelman, V. Deubel, and P. Despres. 1997. Dengue virus replication in human hepatoma cells activates NF-κB which in turn induces apoptotic cell death. J. Virol. 71:3244.
30. Despres, P., M. P. Frenkiel, P. E. Ceccaldi, C. Duarte dos Santos, and V. Deubel. 1998. Apoptosis in the mouse central nervous system in response to infection with mouse-neurovirulent dengue viruses. J. Virol. 72:823.
31. Marianneau, P., M. Flamand, V. Deubel, and P. Despres. 1998. Apoptotic cell death in response to dengue virus infection: the pathogenesis of dengue haemorrhagic fever revisited. Clin. Diagn. Virol. 10:113.
32. Jan, J. T., B. H. Chen, S. H. Ma, C. I. Liu, H. P. Tsai, H. C. Wu, S. Y. Jiang, K. D. Yang, and M. F. Shaio. 2000. Potential dengue virus-triggered apoptotic pathway in human neuroblastoma cells: arachidonic acid, superoxide anion, and NF-κB are sequentially involved. J. Virol. 74:8680.
33. Anderson, R., S. Wang, C. Osiowy, and A. C. Issekutz. 1997. Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes. J. Virol. 71:4226.
34. + cytotoxic T-lymphocyte clones. J. Virol. 73:3623.
35. Nimmannitya, S. 1987. Clinical spectrum and management of dengue haemorrhagic fever. Southeast Asian J. Trop. Med. Pub. Hlth. 18:392.
36. Bhamarapravati, N. 1989. Hemostatic defects in dengue hemorrhagic fever. Rev. Infect. Dis. 11:S826.
37. Kalayanarooj, S., D. W. Vaughn, S. Nimmannitya, S. Green, S. Suntayakorn, N. Kunentrasai, W. Viramitrachai, S. Ratanachueke, S. Kiatpolpoj, B. L. Innis, et al. 1997. Early clinical and laboratory indictors of acute dengue illness. J. Infect. Dis. 176:313.
38. Bosch, I., K. Xhaja, L. Estevez, G. Raines, H. Melichar, R. V. Warke, M. V. Fournier, F. A. Ennis, and A. L. Rothman. 2002. Increased production of interleukin-8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge. J. Virol. 76:5588.
39. Warke, R. V., K. Xhaja, K. J. Martin, M. F. Fournier, S. K. Shaw, N. Brizuela, N. De Bosch, D. Lapointe, F. A. Ennis, A. L. Rothman, and I. Bosch. 2003. Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells. J. Virol. 77:11822.
40. Lin, C. F., H. Y. Lei, A. L. Shiau, H. S. Liu, T. M. Yeh, S. H. Chen, C. C. Liu, S. C. Chiu, and Y. S. Lin. 2002. Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide. J. Immunol. 169:657.
41. Lin, C. F., H. Y. Lei, A. L. Shiau, C. C. Liu, H. S. Liu, T. M. Yeh. S. H. Chen, and Y. S. Lin. 2003. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage. J. Med. Virol. 69:82.
42. Lin, Y. S., C. F. Lin, C. C. Liu, H. S. Liu, T. M. Yeh, S. H. Chen, and H. Y. Lei. 2004. Antibody-mediated endothelial cell damage via nitric oxide. Curr. Pharm. Design 10:213.
43. Lin, Y. L., C. C. Liu, J. I. Chuang, H. Y. Lei, T. M. Yeh, Y. S. Lin, Y. H. Huang, and H. S. Liu. 2000. Involvement of oxidative stress, NF-IL-6, and RANTES expression in dengue-2-virus-infected human liver cells. Virology 276:114.
44. King, C. A., R. Anderson, and J. S. Marshall. 2002. Dengue virus selectively induces human mast cell chemokine production. J. Virol. 76:8408.
45. Kurane, I., B. L. Innis, S. Nimmannitya, A. Nisalak, A. Meager, J. Janus, and F. A. Ennis. 1991. Activation of T lymphocytes in dengue virus infections: high levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-γ in sera of children with dengue. J. Clin. Invest. 88:1473.
46. Hober, D., L. Poli, B. Roblin, P. Gestas, E. Chungue, G. Granic, P. Imbert, J. Pecarere, R. Vergez-Pascal, P. Wattre, and M. Maniez-Montreuil. 1993. Serum levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β) in dengue-infected patients. Am. J. Trop. Med. Hyg. 48:324.
47. Raghupathy, R., U. C. Chaturvedi, H. Al-Sayer, E. A. Elbishbishi, R. Agarwal, R. Nagar, S. Kapoor, A. Misra, A. Mathur, H. Nusrat, et al. 1998. Elevated levels of IL-8 in dengue hemorrhagic fever. J. Med. Virol. 56:280.
48. Juffrie, M., G. M. van Der Meer, C. E. Hack, K. Haasnoot, K. Sutaryo, A. J. Veerman, and L. G. Thijs. 2000. Inflammatory mediators in dengue virus infection in children: interleukin-8 and its relationship to neutrophil degranulation. Infect. Immun. 68:702.
49. Mustafa, A. S., E. A. Elibishbishi, R. Agarwal, and U. C. Chaturvedi. 2001. Elevated levels of interleukin-13 and IL-18 in patients with dengue hemorrhagic fever. FEMS Immunol. Med. Microbiol. 30:229.
50. Gagnon, S. J., M. Mori, I. Kurane, S. Green, D. W. Vaughn, S. Kalayanarooj, S. Suntayakorn, F. A. Ennis, and A. L. Rothman. 2002. Cytokine gene expression and protein production in peripheral blood mononuclear cells of children with acute dengue virus infections. J. Med. Virol. 67:41.
51. Suharti, C., E. C. van Gorp, W. M. Dolmans, T. E. Setiati, C. E. Hack, R. Djokomoeljanto, and J. W. van der Meer. 2003. Cytokine patterns during dengue shock syndrome. Eur. Cytokine Network 14:172.
52. Hung, N. T., H. Y. Lei, N. T. Lan, Y. S. Lin, K. J. Huang, B. Lien le, C. F. Lin, T. M. Yeh, Q. Ha do, V. T. Huong, et al. 2004. Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J. Infect. Dis. 189:221.
53. Frostegard, J., J. Nilsson, A. Haegerstrand, A. Hamsten, H. Wigzell, and M. Gidlund. 1990. Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc. Natl. Acad. Sci. USA 87:904.
54. Adams, M. R., W. Jessup, D. Hailstones, and D. S. Celermajer. 1997. L-Arginine reduces human monocyte adhesion to vascular endothelium and endothelial expression of cell adhesion molecules. Circulation 95:662.
55. Weiss, J. M., S. A. Downie, W. D. Lyman, and J. W. Berman. 1998. Astrocyte-derived monocyte-chemoattractant protein-1 directs the transmigration of leukocytes across a model of the human blood-brain barrier. J. Immunol. 161:6896.
56. Tekstra, J., H. Beekhuizen, J. S. Van De Gevel, I. J. Van Benten, C. W. Tuk, and R. H. Beelen. 1999. Infection of human endothelial cells with Staphylococcus aureus induces the production of monocyte chemotactic protein-1 (MCP-1) and monocyte chemotaxis. Clin. Exp. Immunol. 117:489.
57. Viedt, C., R. Dechend, J. Fei, G. M. Hansch, J. Kreuzer, and S. R. Orth. 2002. MCP-1 induces inflammatory activation of human tubular epithelial cells: involvement of the transcription factors, nuclear factor-κB and activating protein-1. J. Am. Soc. Nephrol. 13:1534.
58. Monath, T. P. 1994. Dengue: the risk to developed and developing countries. Proc. Natl. Acad. Sci. USA 91:2395.
59. Lin, C. F., H. Y. Lei, C. C. Liu, H. S. Liu, T. M. Yeh, S. T. Wang, T. I. Yang, F. C. Sheu, C. F. Kuo, and Y. S. Lin. 2001. Generation of IgM anti-platelet autoantibody in dengue patients. J. Med. Virol. 63:143.
60. Huang, K. J., S. Y. J. Li, S. C. Chen, H. S. Liu, Y. S. Lin, T. M. Yeh, C. C. Liu, and H. Y. Lei. 2000. Manifestation of thrombocytopenia in dengue-2-virus-infected mice. J. Gen. Virol. 81:217.
61. Falconar, A. K. I. 1997. The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Arch. Virol. 142:897.
62. Oishi, K., S. Inoue, M. T. Cinco, E. M. Dimaano, M. T. Alera, J. A. Alfon, F. Abanes, D. J. Cruz, R. R. Matias, H. Matsuura, et al. 2003. Correlation between increased platelet-associated IgG and thrombocytopenia in secondary dengue virus infections. J. Med. Virol. 71:259.
63. Andrews, B. S., A. N. Theofilopoulos, C. J. Peters, D. J. Loskutoff, W. E. Brandt, and F. J. Dixon. 1978. Replication of dengue and junin viruses in cultured rabbit and human endothelial cells. Infect. Immun. 20:776.
64. Jacobs, M. G., P. J. Robinson, C. Bletchly, J. M. Mackenzie, and P. R. Young. 2000. Dengue virus nonstructural protein 1 is expressed in a glycosyl-phosphatidylinositol-linked form that is capable of signal transduction. FASEB J. 14:1603.
65. Carvalho, D., C. O. S. Savage, C. M. Black, and J. D. Pearson. 1996. IgG anti-endothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro: induction of adhesion molecule expression and involvement of endothelial-derived cytokines. J. Clin. Invest. 97:111.
66. Del Papa, N., E. Raschi, G. Moroni, P. Panzeri, M. O. Borghi, C. Ponticelli, A. Tincani, G. Balestrieri, and P. L. Meroni. 1999. Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and a pro-inflammatory phenotype in vitro. Lupus 8:423.
67. Yazici, Z. A., E. Raschi, A. Patel, C. Testoni, M. O. Borghi, A. M. Graham, P. L. Meroni, and N. Lindsey. 2001. Human monoclonal anti-endothelial cell IgG derived from a systemic lupus erythematosus patient binds and activates human endothelium in vitro. Int. Immunol. 13:349.
68. Praprotnik, S., M. Blank, Y. Levy, S. Tavor, M. C. Boffa, B. Weksler, A. Eldor, and Y. Shoenfeld. 2001. Anti-endothelial cell antibodies from patients with thrombotic thrombocytopenic purpura specifically activate small vessel endothelial cells. Int. Immunol. 13:203.
69. Lee, K. H., H. J. Cho, H. S. Kim, W. J. Lee, S. Lee, and D. Bang. 2002. Activation of extracellular signal regulated kinase 1/2 in human dermal microvascular endothelial cells stimulated by anti-endothelial cell antibodies in sera of patients with Behçet's disease. J. Dermatol. Sci. 30:63.
70. Innis, B. L. 1995. Dengue and dengue hemorrhagic fever. In Kass Handbook of Infectious Diseases: Exotic Viral Diseases. J. S. Porterfield, ed. Chapman and Hall, London, p. 103.